Fusion Healthy Aging names three of the compounds this site tracks and publishes nothing else a comparison can use: no figure, no company, no coverage. It is one of the plainest entries on this roster, and short reviews are the honest response to short pages.
What Fusion Healthy Aging charges
Fusion Healthy Aging does not publish a price today.
Fusion Healthy Aging also sells 3 compounds this site boards without publishing a price for them: BPC-157 (board ranks no provider), CJC-1295 (board ranks no provider) and Ipamorelin (board ranks no provider).
Fusion Healthy Aging is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
Three compounds and a category description
The peptide page names three tracked compounds and one this comparison does not follow.
The rest of the page describes what peptide therapy is rather than what this seller supplies.
There is no per-compound page and no catalogue behind the three names.
That is the entire published offer, and it is recorded as such rather than padded.
Three absences, each checked
No dollar sign appears anywhere in the page's joined text, so a figure split across nested elements would still have been found.
No company name appears, on this page or in its footer.
No state list appears, so eligibility is settled after contact rather than before it.
Each of those was looked for on the page that should have carried it, which is what separates an absence from an oversight.
What is not published about cost
The peptide page carries no dollar sign anywhere in its joined text.
No certificate of analysis is claimed anywhere on the pages read, and every attribute was swept rather than only the link targets.
Publishing a figure somewhere on its own site is true of one hundred and thirty-seven of the two hundred and ten sellers here, so it separates far fewer of them than a reader expects.
The host itself was checked in the same pass as everything above: 404 at a nonsense path, same effective path, which is what any absence recorded here rests on.
Where this row sits against the rest
One hundred and seventy-six of the two hundred and ten sellers here publish no state list at all, and this is one of them, so eligibility is settled inside an intake rather than before one.
Sixteen of the two hundred and ten sellers here name the facility that fills an order; this is one of the one hundred and ninety-four that do not, so there is no facility a reader can look up.
Four of the two hundred and ten sellers here describe lab work as included in what they charge, and this is not one of them.
It declares three of the sixteen compounds this site tracks, and eighty-one sellers here declare more, so it is a middling menu by the standards of this roster.
Who it's for
Readers who want a short list of recovery-focused compounds.
Buyers near the seller's own city.
Shoppers who expect to be quoted at a consultation.
Anyone comparing the same three compounds across sellers.
Who should look elsewhere
Anyone who needs a figure.
Readers who want a company name.
Buyers who need a state footprint.
Shoppers looking for anything beyond the three named compounds.
Strengths
Names exactly what it offers without padding the list
Describes what it offers without claiming an approval it does not have
Keeps its peptide offer separate from its other lines on the page
Answers the category question in plain language rather than in a disclaimer
Trade-offs
Publishes no figure, no company name and no state coverage
Publishes no figure for any compound on the pages read
Publishes no corporate entity, so there is no company a reader can look up
Publishes no state list and names no dispensing pharmacy
How we verified this
Read every page cited on this row as rendered text in a browser-equivalent fetch, with the response decompressed before any character was counted.
Fired a nonsense-path control at this host in the same run and compared the address requested with the address actually served, so no claim here rests on a status code alone.
Joined every text node before scanning for a dollar sign, so a figure split across nested elements could not read as an absence.
Screened this seller in the live federal warning-letter record by entity and by brand, with a known-good positive control and a nonsense negative control fired in the same run.
Read the company column of every returned record rather than accepting a full-text match, and attached no letter on a name match.
Swept every attribute on the pages read for a certificate, not only the link targets, because certificates in this market hide in data attributes and lightbox images.
Re-counted the state-list, pharmacy-naming and lab-inclusion claims against the current roster rather than reusing figures from an earlier pass.
A provider to compare Fusion Healthy Aging against
Live Vital
Live Vital lists one of the deeper peptide menus in this roster — tesamorelin, CJC-1295, ipamorelin, BPC-157, TB-500, GHK-Cu, MOTS-C, glutathione and NAD+ — alongside its GLP-1 line, with coverage across all 50 states.